MiraDx's MicroRNA-based Platform Predicts Cancer Treatment Outcomes

MiraDx announced two studies to be presented at ASCO 2025, showcasing their mirSNP platform's ability to predict treatment-related toxicity and respon...
Home/KnloSights/Clinical Trial Updates/MiraDx's MicroRNA-based Platform Predicts Cancer Treatment Outcomes